Hasil Pencarian - Karl-Heinz Klempnauer
- Menampilkan 1 - 7 hasil dari 7
-
1
Transcription Factor MYB as Therapeutic Target: Current Developments oleh Karl-Heinz Klempnauer
Diterbitkan 2024-03-01
Artikel -
2
Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module oleh Thomas J. Schmidt, Karl-Heinz Klempnauer
Diterbitkan 2022-03-01
Artikel -
3
Characterization of the MYB-inhibitory potential of the Pan-HDAC inhibitor LAQ824 oleh Maria V. Yusenko, Karl-Heinz Klempnauer
Diterbitkan 2022-01-01
Artikel -
4
Src-Family Protein Kinase Inhibitors Suppress MYB Activity in a p300-Dependent Manner oleh Abhiruchi Biyanee, Maria V. Yusenko, Karl-Heinz Klempnauer
Diterbitkan 2022-03-01
Artikel -
5
-
6
PRMT4 is a novel coactivator of c-Myb-dependent transcription in haematopoietic cell lines. oleh Gundula Streubel, Caroline Bouchard, Hannah Berberich, Marc S Zeller, Sophia Teichmann, Jürgen Adamkiewicz, Rolf Müller, Karl-Heinz Klempnauer, Uta-Maria Bauer
Diterbitkan 2013-01-01
Artikel -
7
Interaction of the transactivation domain of B-Myb with the TAZ2 domain of the coactivator p300: molecular features and properties of the complex. oleh Ojore Oka, Lorna C Waters, Sarah L Strong, Nuvjeevan S Dosanjh, Vaclav Veverka, Frederick W Muskett, Philip S Renshaw, Karl-Heinz Klempnauer, Mark D Carr
Diterbitkan 2012-01-01
Artikel